跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Kadcyla - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Kadcyla
Approved
STANDARD
Kadcyla
F. Hoffmann-La Roche AG
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e1e1c44cf1557a72
Company
F. Hoffmann-La Roche AG
Type
Standard
Approval Details
Approval Id
e1e1c44cf1557a72
Drug Approval Philippines Name
Kadcyla
Product Name
Kadcyla
Registration Number
BR-953
Brand Name
Kadcyla
Generic Name
Trastuzumab Emtansine
Dosage Form
Powder For Concentrate For Solution For I.V. Infusion
Dosage Strength
100 mg
Manufacturer
F. Hoffmann-La Roche AG
Trader
F. Hoffmann-La Roche Ltd.
Importer
Roche (Philippines) Inc.
Distributor
Roche (Philippines) Inc.
Company Detail Path
/organization/f-hoffmann-la-roche-ag
Trader Detail Path
/organization/f-hoffmann-la-roche-ltd-switzerland
Issuance Date
06 May 2024
Expiry Date
30 June 2029
Pharmacologic Category
Monoclonal Antibody
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e1e1c44cf1557a72
Type
Standard
Back to Philippines FDA Approvals